Phase 2 safety and efficacy: Cystic fibrosis transmembrane conductance regulator (CFTR) modulator regimen VX-445/tezacaftor(TEZ)/ivacaftor(IVA)

08:30 - 08:45

Speaker: Dominc Keating

Infection control practices used in cystic fibrosis centres in Australia and New Zealand

08:45 - 09:00

Speaker: Rebecca Stockwell

Australian adults with cystic fibrosis commonly use exercise as an alternative to traditional airway clearance techniques: A national survey

09:00 - 09:15

Speaker: Nathan Ward

Airway clearance and exercise practices of adults with cystic fibrosis: Current Australian practice

09:15 - 09:30

Speaker: Nathan Ward

Peak glucose level on 30-minutely OGTT is associated with poorer lung function and nutrition in children with CF <10 years of age

09:30 - 09:45

Speaker: Bernadette Prentice

Identifying correlations between dietary intakes and microbiota in cystic fibrosis

09:45 - 10:00

Speaker: Isabelle McKay